Asthma is a chronic disease that affects approximately 4 million people in France and 340 million worldwide. Allergic asthma, which accounts for approximately 50% of asthma cases, is characterized by inflammation of the bronchial tubes and respiratory discomfort caused by inhaling allergens.
In order to fight against allergic asthma, scientists from Inserm, CNRS and Toulouse III-Paul Sabatier University in the Infinity laboratory of the Institut Pasteur and the French company Neovacs have developed a new vaccine. . The findings were published in the scientific journal Allergy. They are promising because theyprovide proof of concept of the vaccine’s efficacy in neutralizing human proteins that play a key role in allergic asthma“.
Related posts:
«Olympic» prepares to compensate against Tajikistan
"Ministry of Health Issues Warning About Dangerous Cold Injection"
Argentina beats Brazil!
J.League YBC Levain Cup Group Stage Results and Advancing Teams: Yokohama FM, Urawa, Nagoya, Fukuoka...
MLS: CF Montreal settles for a draw; Romell Quioto in a select group
NEITHER CRISTIANO NOR MARADONA NOR PELE: Marco Verratti named the best player in all history
Can Viagra Help Prevent Alzheimer's? New Study Suggests a Link
"undetected transmission" in several countries according to